iPierian to Present Data on Tau Antibody Preclinical Efficacy Study...

The presentation will describe in vivo efficacy results in a study of IPN002, the parental version of the lead candidate IPN007.

http://www.hispanicbusiness.com/2013/11/1/ipierian_to_present_data_on_tau.htm